Literature DB >> 20864797

Development of IL-17-mediated delayed-type hypersensitivity is not affected by down-regulation of IL-25 expression.

Akina Ishii1, Keisuke Oboki, Aya Nambu, Hideaki Morita, Tatsukuni Ohno, Naoki Kajiwara, Ken Arae, Hajime Sudo, Ko Okumura, Hirohisa Saito, Susumu Nakae.   

Abstract

BACKGROUND: IL-25, which is a member of the IL-17 family, induces Th2 cell differentiation and Th2 cytokine production, contributing to induction of Th2-type immune responses and diseases, as a result of which it suppresses Th1- and Th17-type immune responses.
METHODS: To elucidate the role of IL-25 in the pathogenesis of IL-17-mediated delayed-type hypersensitivity (DTH), IL-25-deficient mice were sensitized with methylated BSA (mBSA), and then a DTH reaction was induced by mBSA challenge. mBSA-specific T-cell induction was assessed on the basis of cell proliferation and cytokine production. The DTH reaction was evaluated on the basis of tissue swelling, histology and inflammatory mediator expression.
RESULTS: IL-25 expression was markedly reduced in local DTH lesions. However, mBSA-specific Th1, Th2 and Th17 cell induction, and the mBSA-induced DTH reaction were comparable in IL-25-deficient and wild-type mice.
CONCLUSIONS: IL-25 is not essential for differentiation of Th1, Th2 and Th17 cells in the sensitization phase or induction of local inflammation in the elicitation phase of the mBSA-induced DTH reaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864797     DOI: 10.2332/allergolint.10-OA-0218

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  15 in total

1.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

2.  IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease.

Authors:  Bryan C Petersen; Vladislav Dolgachev; Andrew Rasky; Nicholas W Lukacs
Journal:  J Leukoc Biol       Date:  2014-01-09       Impact factor: 4.962

3.  A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma.

Authors:  J A Mathews; J Ford; S Norton; D Kang; A Dellinger; D R Gibb; A Q Ford; H Massay; C L Kepley; P Scherle; A D Keegan; D H Conrad
Journal:  Allergy       Date:  2011-05-10       Impact factor: 13.146

4.  Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock.

Authors:  Eri Shimura; Akiko Shibui; Seiko Narushima; Aya Nambu; Sachiko Yamaguchi; Aoi Akitsu; Warren J Leonard; Yoichiro Iwakura; Kenji Matsumoto; Hajime Suto; Ko Okumura; Katsuko Sudo; Susumu Nakae
Journal:  Biochem Biophys Res Commun       Date:  2014-09-06       Impact factor: 3.575

5.  Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice.

Authors:  Qiang Zou; Xin Yao; Jin Feng; Zhinan Yin; Richard Flavell; Yanxin Hu; Guoxing Zheng; Jin Jin; Youmin Kang; Bing Wu; Xiaoxuan Liang; Congcong Feng; Hu Liu; Weiyi Li; Xianzheng Wang; Yumei Wen; Bin Wang
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

6.  IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis.

Authors:  Wakako Nakanishi; Sachiko Yamaguchi; Akira Matsuda; Maho Suzukawa; Akiko Shibui; Aya Nambu; Kenji Kondo; Hajime Suto; Hirohisa Saito; Kenji Matsumoto; Tatuya Yamasoba; Susumu Nakae
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

7.  Differential Effects of Naja naja atra Venom on Immune Activity.

Authors:  Jian-Qun Kou; Rong Han; Yin-Li Xu; Xiao-Lan Ding; Shu-Zhi Wang; Cao-Xin Chen; Hong-Zhang Ji; Zhi-Hui Ding; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-12       Impact factor: 2.629

8.  IL-25, IL-33 and TSLP receptor are not critical for development of experimental murine malaria.

Authors:  Akiko Shibui; Ayako Takamori; Mohammed E M Tolba; Aya Nambu; Eri Shimura; Sachiko Yamaguchi; Chizu Sanjoba; Hajime Suto; Katsuko Sudo; Ko Okumura; Sumio Sugano; Hideaki Morita; Hirohisa Saito; Kenji Matsumoto; Susumu Nakae
Journal:  Biochem Biophys Rep       Date:  2015-12-14

9.  Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model.

Authors:  Jobu Sugita; Yosuke Asada; Waka Ishida; Satoshi Iwamoto; Katsuko Sudo; Hajime Suto; Toru Matsunaga; Ken Fukuda; Atsuki Fukushima; Norihiko Yokoi; Tatsukuni Ohno; Miyuki Azuma; Nobuyuki Ebihara; Hirohisa Saito; Masato Kubo; Susumu Nakae; Akira Matsuda
Journal:  Immun Inflamm Dis       Date:  2017-07-20

10.  IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice.

Authors:  Hideaki Morita; Ken Arae; Hirotoshi Unno; Sumika Toyama; Kenichiro Motomura; Akio Matsuda; Hajime Suto; Ko Okumura; Katsuko Sudo; Takao Takahashi; Hirohisa Saito; Kenji Matsumoto; Susumu Nakae
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.